Episode

Cracking the Alzheimer’s Code

Podcast
The Swiss Connection
Published
Nov 4, 2025
Duration seconds
1240
Processing state
not_requested
Canonical source
https://www.buzzsprout.com/910414/episodes/18062635-cracking-the-alzheimer-s-code.mp3
Audio
https://www.buzzsprout.com/910414/episodes/18062635-cracking-the-alzheimer-s-code.mp3
JSON
/v1/public/podcasts/the-swiss-connection-1071732/episodes/cracking-the-alzheimer-s-code
Markdown
/podcast/the-swiss-connection-1071732/cracking-the-alzheimer-s-code.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-swiss-connection-1071732/episodes/cracking-the-alzheimer-s-code/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-swiss-connection-1071732/cracking-the-alzheimer-s-code.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Send us Fan Mail Alzheimer’s disease is more than age-related memory loss—it’s a serious brain disorder. In this episode of the Swiss Connection Science podcast, Swissinfo healthcare reporter Jessica Davis Pluess explores the science, hope, and controversy surrounding new Alzheimer’s drugs like Leqembi and Kisunla. With billions invested and global regulatory decisions diverging, what do these treatments mean for patients and healthcare systems? Visit SWI swissinfo.ch for more on this t...